Vol 7, Supplement 1 (March 2018): Translational Andrology and Urology

Editorial

Downstream effects of regionalization: reconciling our predictions with the volume-outcome paradigm
Daniel C. Parker, Nikhil Waingankar
How to assess and improve health-related quality of life in bladder cancer patients
Francesco Soria, Paolo Gontero
Ongoing efforts to reduce perioperative morbidity of radical cystectomy: towards widespread adoption of extended-duration thromboprophylaxis
Vignesh T. Packiam, Joseph J. Pariser
Surviving travel or travelling to survive: the association of travel distance with survival in muscle invasive bladder cancer
Albert H. Kim, Simon P. Kim
Selecting candidates for early discharge after radical cystectomy for bladder cancer
Valérie Fonteyne, Elke Rammant, Karel Decaestecker
Nutritional habits and bladder cancer
Giuseppe Lippi, Daniele Del Rio
Factors affecting urinary incontinence during robotic radical prostatectomy
Mohammad Hajiha, D. Duane Baldwin
A novel bladder cancer urinary biomarker: can it go where no marker has gone before?
Ryan W. Dobbs, Michael R. Abern
Clinical benefit to regionalization of care for muscle invasive bladder cancer
Waqar Haque, E. Brian Butler, Bin S. Teh
Detection of circulating tumor DNA for advanced bladder cancer: where are we going?
Rafael Morales-Barrera, Macarena González, Cristina Suárez, Joan Carles
Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients
Zheng Tan, Ninadh M. D’Costa, Peter A. Raven, Claudia Chavez-Munoz, Alan I. So
Expansion of clinical application of laparoscopic single-site surgery through natural orifice transluminal endoscopic surgery
Jae Hoon Chung, Seung Wook Lee
Urinary biomarker for the detection of recurrence following non- muscle invasive bladder cancer: are we there yet?
Wei Shen Tan, Wei Phin Tan
Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: still many gaps
Massimiliano Creta, Nicola Longo, Ciro Imbimbo, Vittorio Imperatore, Vincenzo Mirone, Ferdinando Fusco
Robot-assisted laparoscopic implantation of brachytherapy catheters in bladder cancer recent interests and prospective
Susovan Banerjee, Srijit Banerjee
Editorial on “Erectile function and oncologic outcomes following open retropubic and robot-assisted radical prostatectomy: results from the LAParoscopic Prostatectomy Robot Open Trial”
Diarmaid Moran, Homayoun Zagar
Robotic-assisted vs. open radical prostatectomy: an update to the never-ending debate
Thenappan Chandrasekar, Derya Tilki
Who benefits most from early salvage radiation therapy after prostatectomy?
Sameer K. Nath, Brent S. Rose, Thomas J. Pugh
Balancing the benefits and harms of radiotherapy post-radical prostatectomy
Benjamin W. Lamb, Omar Alghazo, Declan G. Murphy
Radium-223 for metastatic castration-resistant prostate cancer: results and remaining open issues after the ALSYMPCA trial
Isabel Heidegger, Renate Pichler, Axel Heidenreich, Wolfgang Horninger, Andreas Pircher
Editorial on the value of an immediate intravesical instillation of mitomycin C in patients with non-muscle-invasive bladder cancer
Willem Oosterlinck, Karel Decaestecker
A single immediate instillation of chemotherapy for non-muscle invasive bladder cancer: in all patients?
Richard Sylvester
Anastomotic leaks and catheter time after salvage robot-assisted radical prostatectomy
Marco Bandini, Giorgio Gandaglia, Nicola Fossati, Francesco Montorsi, Alberto Briganti